APOE and atherosclerosis: Several mimetics of apoA-I and apoE have succeeded in preventing atherosclerosis in animal models [10,11,33]; however, human clinical trials involving ApoA-I apolipoprotein mimetic peptides have failed to prove a clinical benefit [18,32].